National clinical practice guidelines for allergen immunotherapy: An international assessment applying AGREE-II
Background: Since 1988, numerous allergen immunotherapy guidelines (AIT-GLs) have been developed by national and international organizations to guide physicians in AIT. Even so, AIT is still severely underused. Objective To evaluate AIT-GLs with AGREE-II, developed in 2010 by McMaster University met...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2018
|
| In: |
Allergy
Year: 2017, Jahrgang: 73, Heft: 3, Pages: 664-672 |
| ISSN: | 1398-9995 |
| DOI: | 10.1111/all.13316 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1111/all.13316 Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/all.13316 
|
| Verfasserangaben: | D.E.S. Larenas‐Linnemann, D. Antolín‐Amérigo, C. Parisi, A. Nakonechna, J.A. Luna‐Pech, B. Wedi, I. Davila, M. Gómez, M. Levin, J.A. Ortega Martell, L. Klimek, N. Rosario, A.M. Muraro, I. Agache, J. Bousquet, A. Sheikh, EAACI International Societies Council, O. Pfaar |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1581376502 | ||
| 003 | DE-627 | ||
| 005 | 20220815022118.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180927r20182017xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/all.13316 |2 doi | |
| 035 | |a (DE-627)1581376502 | ||
| 035 | |a (DE-576)511376502 | ||
| 035 | |a (DE-599)BSZ511376502 | ||
| 035 | |a (OCoLC)1341019480 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Larenas-Linnemann de Martínez, Désirée E.S. |d 1964- |e VerfasserIn |0 (DE-588)1167971256 |0 (DE-627)1031668020 |0 (DE-576)454732112 |4 aut | |
| 245 | 1 | 0 | |a National clinical practice guidelines for allergen immunotherapy |b An international assessment applying AGREE-II |c D.E.S. Larenas‐Linnemann, D. Antolín‐Amérigo, C. Parisi, A. Nakonechna, J.A. Luna‐Pech, B. Wedi, I. Davila, M. Gómez, M. Levin, J.A. Ortega Martell, L. Klimek, N. Rosario, A.M. Muraro, I. Agache, J. Bousquet, A. Sheikh, EAACI International Societies Council, O. Pfaar |
| 264 | 1 | |c 2018 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 21 September 2017 | ||
| 500 | |a Gesehen am 27.09.2018 | ||
| 520 | |a Background: Since 1988, numerous allergen immunotherapy guidelines (AIT-GLs) have been developed by national and international organizations to guide physicians in AIT. Even so, AIT is still severely underused. Objective To evaluate AIT-GLs with AGREE-II, developed in 2010 by McMaster University methodologists to comprehensively evaluate GL quality. Methods Allergist, from different continents, knowledgeable in AIT and AGREE-II trained were selected into the project team. The project received methodologists’ guidance. AIT-GLs in any language were sought from 1980 to 2016; AIT-GLs were AGREE II-evaluated by at least 2 team members, independently; discrepancies were resolved in a second round, by team discussion or methodologists’ consulting. Results We found 31 AIT-GLs (15 post-2010), ranging from local consensus reports to international position papers (EAACI, AAAAI-ACAAI, WAO). Pre-2010 GLs scored 1.6-4.6 (23%-67%) and post-2010 GLs scored 2.1-6 (30%-86%), on a 7-point Likert scale. The highest scores went to: German-Austrian-Swiss (6.0), Mexican (5.1), and the AAAAI/ACAAI AIT-GL (4.7). These were also the only 3 GLs that received “yes” of both evaluators to the item: “I would recommend this GL for use.” The domains of “Stakeholder involvement” and “Rigor of Development” only scored 3/7, and “Applicability” scored the lowest. Strikingly, newer GLs only scored clearly better in “Editorial independence” and “Global evaluation.” Conclusions: In AIT-GLs, there is still a lot of room for improvement, especially in domains crucial for the dissemination. For some GLs, the “Scientific rigor” domain flawed. When resources are limited, transculturizing a high-quality GL might be preferable over developing a GL from zero. Our study and AGREE-II could help to select the best candidate. Clinical Implications We here evaluate allergen immunotherapy guideline (AIT-GL) quality. Only high-quality AIT-GLs should be consulted for AIT management decisions. In low-resource settings, transculturization of these is preferred over developing low-quality guidelines. | ||
| 534 | |c 2017 | ||
| 650 | 4 | |a AGREE II instrument | |
| 650 | 4 | |a allergen immunotherapy | |
| 650 | 4 | |a allergic rhinitis | |
| 650 | 4 | |a subcutaneous immunotherapy | |
| 650 | 4 | |a sublingual immunotherapy | |
| 700 | 1 | |a Pfaar, Oliver |d 1972- |e VerfasserIn |0 (DE-588)12385900X |0 (DE-627)706454049 |0 (DE-576)293913099 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Allergy |d Oxford : Wiley, 1978 |g 73(2018), 3, Seite 664-672 |h Online-Ressource |w (DE-627)320425428 |w (DE-600)2003114-2 |w (DE-576)091140153 |x 1398-9995 |7 nnas |a National clinical practice guidelines for allergen immunotherapy An international assessment applying AGREE-II |
| 773 | 1 | 8 | |g volume:73 |g year:2018 |g number:3 |g pages:664-672 |g extent:9 |a National clinical practice guidelines for allergen immunotherapy An international assessment applying AGREE-II |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/all.13316 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/all.13316 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180927 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 12385900X |a Pfaar, Oliver |m 12385900X:Pfaar, Oliver |d 60000 |d 62100 |e 60000PP12385900X |e 62100PP12385900X |k 0/60000/ |k 1/60000/62100/ |p 17 |y j | ||
| 999 | |a KXP-PPN1581376502 |e 3027338021 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["First published: 21 September 2017","Gesehen am 27.09.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1581376502","person":[{"roleDisplay":"VerfasserIn","display":"Larenas-Linnemann de Martínez, Désirée E.S.","role":"aut","family":"Larenas-Linnemann de Martínez","given":"Désirée E.S."},{"role":"aut","display":"Pfaar, Oliver","roleDisplay":"VerfasserIn","given":"Oliver","family":"Pfaar"}],"title":[{"title_sort":"National clinical practice guidelines for allergen immunotherapy","title":"National clinical practice guidelines for allergen immunotherapy","subtitle":"An international assessment applying AGREE-II"}],"physDesc":[{"extent":"9 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Oxford ; Oxford","publisher":"Wiley ; Blackwell Munksgaard","dateIssuedKey":"1978","dateIssuedDisp":"1978-"}],"id":{"zdb":["2003114-2"],"eki":["320425428"],"doi":["10.1111/(ISSN)1398-9995"],"issn":["1398-9995"]},"note":["Gesehen am 14.08.14"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"National clinical practice guidelines for allergen immunotherapy An international assessment applying AGREE-IIAllergy","language":["eng"],"recId":"320425428","pubHistory":["33.1978 -"],"part":{"year":"2018","pages":"664-672","issue":"3","volume":"73","text":"73(2018), 3, Seite 664-672","extent":"9"},"title":[{"title_sort":"Allergy","title":"Allergy"}]}],"name":{"displayForm":["D.E.S. Larenas‐Linnemann, D. Antolín‐Amérigo, C. Parisi, A. Nakonechna, J.A. Luna‐Pech, B. Wedi, I. Davila, M. Gómez, M. Levin, J.A. Ortega Martell, L. Klimek, N. Rosario, A.M. Muraro, I. Agache, J. Bousquet, A. Sheikh, EAACI International Societies Council, O. Pfaar"]},"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"id":{"doi":["10.1111/all.13316"],"eki":["1581376502"]}} | ||
| SRT | |a LARENASLINNATIONALCL2018 | ||